Is BPC-157 FDA-approved?

No. BPC-157 is not FDA-approved for any indication. It is classified as an investigational compound. Compounded BPC-157 available through kindr Health is prepared by VialsRX under the 503A compounding framework. It is not a pharmaceutical drug and has not been evaluated by the FDA for safety, efficacy, or quality.

What is the evidence base?

BPC-157 has an extensive preclinical research record primarily in animal models. Human clinical trial data is very limited. kindr Health does not make efficacy claims for BPC-157 in humans. Your physician will review the available evidence with you and help you make an informed decision.

How is BPC-157 administered?

Typically via subcutaneous injection, sometimes oral capsules or nasal spray depending on the intended application. Route and dosing are determined by your physician.

Who prescribes BPC-157?

Licensed physicians at Arora Health & Aesthetics, LLC. Not all physicians will prescribe BPC-157 given the limited human trial data. Your physician will make a clinical determination based on your specific situation.

Who compounds BPC-157?

VialsRX, 6220 Westpark Dr, Houston TX. USP-compliant sterile compounding lab. All 50 US states.

What are the side effects?

Based on preclinical research and clinical anecdote, BPC-157 is generally considered well-tolerated. Reported effects include injection site reactions, dizziness (rare), and nausea (rare). Given the limited human trial data a complete side effect profile has not been formally established.

Can BPC-157 be combined with other peptides?

Some physicians prescribe BPC-157 alongside other peptides such as sermorelin or TB-500 depending on clinical goals. Your physician will determine the appropriate protocol for your situation.

Part of the pillar guide: Peptide Therapy — Complete Guide

kindr

Pentadecapeptide · Gut + Joint + Tissue

BPC-157. The body's own repair signal — amplified.

BPC-157 (Body Protection Compound) is a pentadecapeptide derived from a protein found in gastric juice. Studied extensively for its effects on tissue repair, gut healing, joint regeneration, and inflammatory response in preclinical research.

BPC-157 research is primarily preclinical (animal studies). Human clinical trials are limited. Physician evaluation is required and a prescription is not guaranteed.

Request Physician Evaluation →

· Physician evaluation required· Licensed 503A pharmacy· All 50 US states

15 AA

Amino acid chain — the peptide sequence of BPC-157

Gastric

Derived from a protein naturally present in gastric juice

Preclinical

Evidence base — extensive animal studies, limited human trials

BPC-157 is an investigational compound. Not FDA-approved. Compounded by VialsRX under 503A. Physician evaluation required.

What the research shows about BPC-157.

Preclinical disclaimer. The evidence for BPC-157 is primarily from preclinical research — animal studies and in vitro research. Well-designed human clinical trials are limited. This page presents the available research with appropriate context. kindr Health does not make claims about efficacy in humans.

Gut and digestive healing

BPC-157 has been studied extensively in animal models for effects on the gastrointestinal tract — including gastric ulcer healing, inflammatory bowel conditions, and gut mucosal repair. The peptide appears to upregulate growth hormone receptor expression in the gut lining.

Joint and tendon repair

Animal studies show accelerated healing of ligament, tendon, and bone injuries with BPC-157 administration. This has made it popular among athletes and biohackers seeking recovery support.

Anti-inflammatory effects

Preclinical research demonstrates modulation of inflammatory pathways including nitric oxide system effects. May reduce systemic inflammation in animal models.

Neurological research

Some animal research suggests potential neuroprotective effects and dopamine system interaction. This area of research is early-stage.

Cardiovascular

Animal models suggest effects on blood pressure regulation and vascular repair mechanisms. Human data is very limited.

Understanding the evidence.

BPC-157 has accumulated an extensive preclinical research record over several decades — primarily through the work of Dr. Predrag Sikiric at the University of Zagreb. Animal studies consistently show impressive healing and anti-inflammatory effects across multiple tissue types and administration routes.

The limitation is clear: the overwhelming majority of BPC-157 studies are in animal models. The translation from animal to human pharmacology is not guaranteed and varies significantly across compounds. As of the time this page was written no large-scale randomized controlled human trials have been completed and published.

This does not mean BPC-157 is ineffective in humans — it means we do not yet have the clinical trial evidence to make strong efficacy claims. The physician community remains divided. Some physicians prescribe it based on the preclinical record and patient anecdote. Others wait for human trial data.

What your physician will evaluate. Your kindr physician will review the preclinical evidence with you, assess your specific situation, and help you make an informed decision about whether BPC-157 is appropriate for your goals and health history.

Administration routes.

Subcutaneous injection

Most studied route. Typically administered near the site of injury or concern. Physician will provide specific injection instructions.

Oral / capsule

Some evidence for systemic gut effects via oral administration. Less studied than injectable routes.

Nasal spray

Used for neurological applications in some protocols. Less common.

Route and dosing are determined by your prescribing physician based on your specific goals and health history.

How it works at kindr.

Complete intake form

A medical questionnaire to be reviewed by a licensed physician.

Physician evaluation within 24 hours

An independent physician at Arora Health & Aesthetics evaluates your submission.

Prescription sent to VialsRX

If clinically appropriate, your prescription is sent to the licensed 503A compounding pharmacy.

Ships in 24-48 hours

Your physician will provide specific administration instructions based on the prescribed route.

Pharmacy disclosure: Compounded BPC-157 is prepared by VialsRX, 6220 Westpark Dr, Houston TX 77057 — a USP-compliant 503A compounding pharmacy. Compounded medications are not FDA-approved.

Request your BPC-157 evaluation.

Complete this form to be evaluated for compounded BPC-157. A licensed physician will review your submission within 24 hours.

Full name

Email address

Phone number

Date of birth

State of residence

Current weight

Height

Primary concern

Current medical conditions

IBD or IBSJoint or tendon injuryHypertensionHigh cholesterolType 2 diabetesHistory of cancerNone of the above

Current medications

Additional information

I understand that BPC-157 is an investigational compound not approved by the FDA and that its evidence base is primarily preclinical. I consent to physician evaluation and understand that a prescription is not guaranteed.I consent to the collection and processing of my health information in accordance with kindr Health's HIPAA Privacy Notice.

BPC-157 is an investigational compound not approved by the FDA. Compounded by VialsRX under 503A. Clinical services by Arora Health & Aesthetics LLC. Prescription not guaranteed.

Frequently asked questions.

BPC-157 (Body Protection Compound) is a pentadecapeptide — a chain of 15 amino acids — derived from a protein found in gastric juice. It has been studied extensively in preclinical research for its effects on tissue healing, gut repair, joint health, and inflammatory response. Available as a compounded medication through physician evaluation.

Start your BPC-157 evaluation. Physician-supervised.

Request Evaluation →

BPC-157 is an investigational compound not approved by the FDA. Evidence base is primarily preclinical. Compounded by VialsRX under 503A. Clinical services by Arora Health & Aesthetics LLC. Prescription not guaranteed.

Related kindr resources

Sermorelin →CJC-1295 + Ipamorelin →Retatrutide →

Keep reading

Sermorelin

Growth-hormone-releasing hormone analog for recovery and sleep.

Read Sermorelin →

GHK-Cu

Copper peptide that supports skin, hair, and connective tissue.

Read GHK-Cu →

CJC-1295 / Ipamorelin

GHRH + ghrelin agonist combo for endogenous GH support.

Read CJC-1295 / Ipamorelin →

Medically reviewed by Dr. Ana Lisa Carr, MD, MBA
Board-Certified Family Medicine Physician · Lead Provider / Medical Reviewer
NPI 1689841744 · Last reviewed: May 10, 2026

Latest from the Journal

Weight & metabolism
HRT vs GLP-1 for menopause weight loss: which is right for you?
Hormone therapy addresses the hormonal causes of midlife weight gain. GLP-1s like semaglutide target appetite and metabolism. Here is how they differ — and when to use one, the other, or both.
Read HRT vs GLP-1 for menopause weight loss: which is right for you? →
Lifestyle
Strength training in menopause: the single most important habit after 40
Estrogen loss accelerates muscle and bone decline. Resistance training — done correctly — is the closest thing we have to a medication for it.
Read Strength training in menopause: the single most important habit after 40 →
Perimenopause
Understanding perimenopause: the years before menopause
Perimenopause can begin in your late 30s or 40s and last up to a decade. Here is what is happening hormonally and what actually helps.
Read Understanding perimenopause: the years before menopause →